Increased ST6Gal1 expression was reported in pancreatic, prostate, breast, and ovarian cancer, and was implicated as contributing to tumor growth, metastasis, and signal transduction pathways relevant to tumorigenesis (8–15). Here, ST6GAL1 is linked to neoplasm.